Literature DB >> 24344267

Effective functional maturation of invariant natural killer T cells is constrained by negative selection and T-cell antigen receptor affinity.

Romain Bedel1, Richard Berry, Thierry Mallevaey, Jennifer L Matsuda, Jingjing Zhang, Dale I Godfrey, Jamie Rossjohn, John W Kappler, Philippa Marrack, Laurent Gapin.   

Abstract

The self-reactivity of their T-cell antigen receptor (TCR) is thought to contribute to the development of immune regulatory cells, such as invariant NK T cells (iNKT). In the mouse, iNKT cells express TCRs composed of a unique Vα14-Jα18 rearrangement and recognize lipid antigens presented by CD1d molecules. We created mice expressing a transgenic TCR-β chain that confers high affinity for self-lipid/CD1d complexes when randomly paired with the mouse iNKT Vα14-Jα18 rearrangement to study their development. We show that although iNKT cells undergo agonist selection, their development is also shaped by negative selection in vivo. In addition, iNKT cells that avoid negative selection in these mice express natural sequence variants of the canonical TCR-α and decreased affinity for self/CD1d. However, limiting the affinity of the iNKT TCRs for "self" leads to inefficient Egr2 induction, poor expression of the iNKT lineage-specific zinc-finger transcription factor PLZF, inadequate proliferation of iNKT cell precursors, defects in trafficking, and impaired effector functions. Thus, proper development of fully functional iNKT cells is constrained by a limited range of TCR affinity that plays a key role in triggering the iNKT cell-differentiation pathway. These results provide a direct link between the affinity of the TCR expressed by T-cell precursors for self-antigens and the proper development of a unique population of lymphocytes essential to immune responses.

Entities:  

Keywords:  deletion; thymus

Mesh:

Substances:

Year:  2013        PMID: 24344267      PMCID: PMC3890789          DOI: 10.1073/pnas.1320777110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

Review 1.  The biology of NKT cells.

Authors:  Albert Bendelac; Paul B Savage; Luc Teyton
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

Review 2.  CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system.

Authors:  Jennifer L Matsuda; Thierry Mallevaey; James Scott-Browne; Laurent Gapin
Journal:  Curr Opin Immunol       Date:  2008-05-22       Impact factor: 7.486

3.  Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells.

Authors:  Jens Schümann; Paola Pittoni; Elena Tonti; H Robson Macdonald; Paolo Dellabona; Giulia Casorati
Journal:  J Immunol       Date:  2005-12-01       Impact factor: 5.422

4.  A molecular basis for NKT cell recognition of CD1d-self-antigen.

Authors:  Thierry Mallevaey; Andrew J Clarke; James P Scott-Browne; Mary H Young; Laila C Roisman; Daniel G Pellicci; Onisha Patel; Julian P Vivian; Jennifer L Matsuda; James McCluskey; Dale I Godfrey; Philippa Marrack; Jamie Rossjohn; Laurent Gapin
Journal:  Immunity       Date:  2011-03-03       Impact factor: 31.745

5.  T cell receptor CDR2 beta and CDR3 beta loops collaborate functionally to shape the iNKT cell repertoire.

Authors:  Thierry Mallevaey; James P Scott-Browne; Jennifer L Matsuda; Mary H Young; Daniel G Pellicci; Onisha Patel; Meena Thakur; Lars Kjer-Nielsen; Stewart K Richardson; Vincenzo Cerundolo; Amy R Howell; James McCluskey; Dale I Godfrey; Jamie Rossjohn; Philippa Marrack; Laurent Gapin
Journal:  Immunity       Date:  2009-07-17       Impact factor: 31.745

6.  The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions.

Authors:  Damian Kovalovsky; Olisambu U Uche; Sonia Eladad; Robin M Hobbs; Woelsung Yi; Eric Alonzo; Kevin Chua; Maggie Eidson; Hye-Jung Kim; Jin S Im; Pier Paolo Pandolfi; Derek B Sant'Angelo
Journal:  Nat Immunol       Date:  2008-07-27       Impact factor: 25.606

7.  Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loop.

Authors:  Mark A Exley; Runhua Hou; Angela Shaulov; Elena Tonti; Paolo Dellabona; Giulia Casorati; Omid Akbari; H Orhan Akman; Edward A Greenfield; Jenny E Gumperz; Jonathan E Boyson; Steven P Balk; S Brian Wilson
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

8.  The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells.

Authors:  Vanja Lazarevic; Alfred J Zullo; Michelle N Schweitzer; Tracy L Staton; Elena M Gallo; Gerald R Crabtree; Laurie H Glimcher
Journal:  Nat Immunol       Date:  2009-01-25       Impact factor: 25.606

9.  Characterization of the early stages of thymic NKT cell development.

Authors:  Kamel Benlagha; Datsen G Wei; Joel Veiga; Luc Teyton; Albert Bendelac
Journal:  J Exp Med       Date:  2005-08-08       Impact factor: 14.307

10.  The transcription factor PLZF directs the effector program of the NKT cell lineage.

Authors:  Adam K Savage; Michael G Constantinides; Jin Han; Damien Picard; Emmanuel Martin; Bofeng Li; Olivier Lantz; Albert Bendelac
Journal:  Immunity       Date:  2008-08-14       Impact factor: 31.745

View more
  19 in total

Review 1.  The ins and outs of type I iNKT cell development.

Authors:  Susannah C Shissler; Tonya J Webb
Journal:  Mol Immunol       Date:  2018-11-28       Impact factor: 4.407

Review 2.  Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge.

Authors:  Daniel G Pellicci; Hui-Fern Koay; Stuart P Berzins
Journal:  Nat Rev Immunol       Date:  2020-06-24       Impact factor: 53.106

3.  Key Residues at Third CDR3β Position Impact Structure and Antigen Recognition of Human Invariant NK TCRs.

Authors:  Kenji Chamoto; Tingxi Guo; Stephen W Scally; Yuki Kagoya; Mark Anczurowski; Chung-Hsi Wang; Muhammed A Rahman; Kayoko Saso; Marcus O Butler; Priscilla P L Chiu; Jean-Philippe Julien; Naoto Hirano
Journal:  J Immunol       Date:  2016-12-21       Impact factor: 5.422

Review 4.  Check MAIT.

Authors:  Laurent Gapin
Journal:  J Immunol       Date:  2014-05-15       Impact factor: 5.422

Review 5.  The self-obsession of T cells: how TCR signaling thresholds affect fate 'decisions' and effector function.

Authors:  Kristin A Hogquist; Stephen C Jameson
Journal:  Nat Immunol       Date:  2014-09       Impact factor: 25.606

6.  Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis.

Authors:  Igor Maricic; Idania Marrero; Akiko Eguchi; Ryota Nakamura; Casey D Johnson; Suryasarathi Dasgupta; Carolyn D Hernandez; Phirum Sam Nguyen; Austin D Swafford; Rob Knight; Ariel E Feldstein; Rohit Loomba; Vipin Kumar
Journal:  J Immunol       Date:  2018-10-15       Impact factor: 5.422

7.  The Protein Phosphatase Shp1 Regulates Invariant NKT Cell Effector Differentiation Independently of TCR and Slam Signaling.

Authors:  Mayra Cruz Tleugabulova; Meng Zhao; Irene Lau; Meggie Kuypers; Clarissa Wirianto; Juan Mauricio Umaña; Qiaochu Lin; Mitchell Kronenberg; Thierry Mallevaey
Journal:  J Immunol       Date:  2019-02-22       Impact factor: 5.422

8.  CDR3β sequence motifs regulate autoreactivity of human invariant NKT cell receptors.

Authors:  Kenji Chamoto; Tingxi Guo; Osamu Imataki; Makito Tanaka; Munehide Nakatsugawa; Toshiki Ochi; Yuki Yamashita; Akiko M Saito; Toshiki I Saito; Marcus O Butler; Naoto Hirano
Journal:  J Autoimmun       Date:  2015-12-31       Impact factor: 7.094

Review 9.  Development of invariant natural killer T cells.

Authors:  Laurent Gapin
Journal:  Curr Opin Immunol       Date:  2016-01-21       Impact factor: 7.486

Review 10.  Endogenous lipid antigens for invariant natural killer T cells hold the reins in adipose tissue homeostasis.

Authors:  Robert J van Eijkeren; Olga Krabbe; Marianne Boes; Henk S Schipper; Eric Kalkhoven
Journal:  Immunology       Date:  2017-10-26       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.